Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Adjunctive Melatonin Gel With Minimally Invasive Non-Surgical Therapy on Clinical Outcomes, Inflammatory Biomarkers and Glycemic Control in Type II Diabetics With Stage III-IV Periodontitis: A Randomized Controlled Clinical Trial

NCT07928752 is registered in ClinicalTrials.gov with Badr University as lead sponsor.

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing

Get the NCT07928752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Follow this trial by email

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Adjunctive Melatonin Gel With Minimally Invasive Non-Surgical Therapy on Clinical Outcomes, Inflammatory Biomarkers and Glycemic Control in Type II Diabetics With Stage III-IV Periodontitis: A Randomized Controlled Clinical Trial
Lead sponsor
Badr University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
April 30, 2027
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabete mellitus, periodontitis

Arms

As registered; 2 arms.

  • MINST + Melatonin Gel Experimental5% Melatonin Gel, Minimally Invasive Non-Surgical Periodontal Therapy (MINST)

    Participants will receive minimally invasive non-surgical periodontal therapy (MINST), followed by adjunctive subgingival application of 5% melatonin gel into selected periodontal pockets using a syringe equipped with a suitable cannula, once weekly for four consecutive weeks.

  • MINST Alone Active comparatorMinimally Invasive Non-Surgical Periodontal Therapy (MINST)

    Participants will receive minimally invasive non-surgical periodontal therapy (MINST) alone, without adjunctive melatonin gel.

Primary endpoints

Registered primary outcome measures; 1 primary.

  • Clinical Attachment Level (CAL) from enrollment to 4 weeks then to the end of the study at 8 weeks

    Change in clinical attachment level (CAL) from baseline to follow-up (measured in mm) following minimally invasive non-surgical periodontal therapy (MINST) with or without adjunctive local application of 5% melatonin gel.

Lead sponsor's other trials

Badr University, most recent start first.

Similar trials

Same condition (Periodontitis) and phase, most recent start first.